{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:05:43Z","timestamp":1784005543996,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Introduction<\/jats:title>\n Traditional Chinese Medicine (TCM) Combined with Methimazole (MMI) versus MMI Alone for Thyroid Function and Autoantibodies in Graves\u2019 Disease(GD).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A systematic literature search was performed in PubMed, Cochrane Library, Web of Science, EMBASE, CNKI, VIP, CBM, and Wanfang databases up to June 2025 for RCTs comparing TCM plus MMI versus MMI alone. Study risk of bias was evaluated using the Cochrane tool. We assessed transitivity to ensure intervention comparability, verified consistency via node-splitting analysis, and planned sensitivity analysis according to risk-of-bias classification. A network meta-analysis was conducted in Stata 15.1 using a random-effects model. Results are reported as mean differences (MD) or standardized mean differences (SMD) with 95% confidence intervals (CI), and treatment efficacy was ranked using SUCRA values.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A network meta-analysis of 15 RCTs involving 1,317 GD patients and 14 TCM plus MMI regimens showed potential advantages over MMI alone in improving thyroid function indices and reducing selected autoantibodies, particularly TRAb and TPOAb. Adverse events were summarized descriptively because AE reporting was incomplete and heterogeneous across the included RCTs. Regarding SUCRA rankings, the Modified Huagan Decoction (MHD) + MMI ranked first for reducing FT3 (SUCRA\u00a0=\u00a093.4%), the Modified Xiaoyao Powder (MXYP) + MMI ranked first for reducing FT4 (SUCRA\u00a0=\u00a097.3%), and the Xiaoyao Powder (XYP) + MMI ranked first for regulating TSH (SUCRA\u00a0=\u00a096.3%). For decreasing TRAb, the MHD + MMI regimen ranked first (SUCRA\u00a0=\u00a088.2%), while for lowering TPOAb, the Huotan Jiangni Formula (HJF) + MMI showed the highest SUCRA ranking (SUCRA\u00a0=\u00a0100%).<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n TCM combined with MMI may have beneficial effects on thyroid function and selected autoantibody levels, particularly TRAb and TPOAb, in GD patients versus MMI alone. Among the evaluated regimens, MHD + MMI, MXYP + MMI, XYP + MMI, and HJF + MMI showed high SUCRA rankings for specific outcomes, including FT3, FT4, TSH, TRAb, and TPOAb. These findings suggest that TCM plus MMI may be a promising short-term adjunctive strategy for initial GD treatment, although safety evidence remains limited by incomplete and inconsistent AE reporting.<\/jats:p>\n <\/jats:sec>\n \n Systematic review registration<\/jats:title>\n \n https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n , identifier CRD420251151307.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2026.1767935","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:22:09Z","timestamp":1784002929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of methimazole combined with traditional Chinese medicine in the treatment of Graves\u2019 disease: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Tiantian","family":"Kuan","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Peking University (PKU)-Shenzhen Clinical Institute of Shantou University Medical College","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Tian","sequence":"additional","affiliation":[{"name":"Shenzhen University Clinical Medical Academy Center, Shenzhen University","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiran","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Peking University (PKU)-Shenzhen Clinical Institute of Shantou University Medical College","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Peking University (PKU)-Shenzhen Clinical Institute of Shantou University Medical College","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Peking University (PKU)-Shenzhen Clinical Institute of Shantou University Medical College","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5603\/NMR.2015.0026","article-title":"Diagnosis and treatment of Graves\u2019 disease with particular emphasis on appropriate techniques in nuclear medicine. General state of knowledge","volume":"18","author":"Prasek","year":"2015","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C299","article-title":"Diagnosis and treatment of Graves disease","volume":"37","author":"Streetman","year":"2003","journal-title":"Ann Pharmacother"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1411459","article-title":"Effect of traditional Chinese medicine on Graves\u2019 disease: a network meta-analysis","volume":"15","author":"Yang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Intern Emerg Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Systematic Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4172","article-title":"Multivariate meta-analysis: potential and promise","volume":"30","author":"Jackson","year":"2011","journal-title":"Stat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2025.112457","article-title":"Network meta-analysis of various surgical approaches for the treatment of posterolateral tibial plateau fractures","volume":"56","author":"Jiang","year":"2025","journal-title":"Injury"},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias visualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"B13","article-title":"Clinical efficacy of Yingliu treatment for Graves disease","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2016.1260595","article-title":"Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines","volume":"55","author":"Yang","year":"2017","journal-title":"Pharm Biol"},{"key":"B15","first-page":"00209","article-title":"Clinical observation on the therapeutic efficacy of integrated traditional Chinese and Western medicine in the treatment of Graves\u2019 hyperthyroidism","volume-title":"Chinese Scientific and Technological Journal Database (Abstract Edition): Medicine and Health Care","author":"Zhao","year":"2016"},{"key":"B16","article-title":"Clinical study on Ziyin Xiaoying formula in the treatment of hyperthyroidism (Graves\u2019 disease) with syndrome of liver\u2013kidney yin deficiency and toxin damaging collaterals","volume-title":"Changchun University of Chinese Medicine","author":"Shi","year":"2017"},{"key":"B17","unstructured":"Clinical study on Xiehuo Xiaoying formula combined with methimazole for treating hyperthyroidism at the initial treatment stage with syndrome of excessive heart and liver fire\n \n \n \n Zhao\n Y\n \n \n \n 2017"},{"key":"B18","unstructured":"Clinical observation on the effect of Shugan Xiaojiu formula on thyroid function in patients with hyperthyroidism\n \n \n \n Wang\n X\n \n \n \n 2018"},{"key":"B19","first-page":"98","article-title":"Clinical observation on the therapeutic efficacy of Huotan Jiangni formula combined with methimazole in the treatment of Graves\u2019 disease","volume":"27","author":"Ji","year":"2018","journal-title":"Chin Natl Folk Med"},{"key":"B20","article-title":"Clinical observation on the therapeutic efficacy of Longmu Xiaoyao powder in the treatment of Graves\u2019 disease of the excessive heart\u2013liver fire type","volume-title":"Henan University of Chinese Medicine","author":"Jia","year":"2019"},{"key":"B21","article-title":"Retrospective study on the effect of Astragalus-based preparations on serum thyrotropin receptor antibody (TRAb) levels in patients with Graves\u2019 disease","volume":"54","author":"Dai","year":"2020","journal-title":"Shanghai J Traditional Chin Med"},{"key":"B22","article-title":"Clinical observation on the therapeutic efficacy of Sanjie Xiaoying decoction in the treatment of toxic diffuse goiter (Graves\u2019 disease)","volume":"41","author":"Tian","year":"2020","journal-title":"J Yunnan Traditional Chin Med Materia Med"},{"key":"B23","article-title":"Clinical efficacy of modified Xiaoyao powder combined with methimazole tablets in patients with Graves\u2019 disease of Qi stagnation and phlegm coagulation syndrome","volume-title":"Journal of Hunan University of Chinese Medicine","author":"Duan","year":"2023"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.20002\/j.issn.1000-7156.2023.06.010","article-title":"Clinical observation on modified Huagan decoction in the treatment of Graves\u2019 disease with hyperactive liver fire syndrome","volume":"39","author":"Xia","year":"2023","journal-title":"Shanxi J Traditional Chin Med"},{"key":"B25","article-title":"Clinical study on the treatment of Graves\u2019 disease (hyperactivity of heart and liver fire syndrome) based on the theory of dislocation of ministerial fire","volume-title":"Chengdu University of Traditional Chinese Medicine","author":"Liu","year":"2023"},{"key":"B26","article-title":"Clinical observation on the therapeutic efficacy of modified Yueju pill in the treatment of Graves\u2019 disease with phlegm\u2013Qi stagnation syndrome","volume-title":"Hunan University of Chinese Medicine","author":"Xia","year":"2024"},{"key":"B27","unstructured":"Exploring the therapeutic efficacy and material basis of Haizao Yuhu decoction for the treatment of Graves\u2019 disease based on network pharmacology and metabolomics\n \n \n \n Huang\n W\n \n \n \n 2024"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.862831","article-title":"New therapeutic horizon of Graves\u2019 hyperthyroidism: treatment regimens based on immunology and ingredients from traditional Chinese medicine","volume":"13","author":"He","year":"2022","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01197","article-title":"Cytokine secretion and pyroptosis of thyroid follicular cells mediated by enhanced NLRP3, NLRP1, NLRC4, and AIM2 inflammasomes are associated with autoimmune thyroiditis","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.579648","article-title":"Innate immune-modulatory activity of Prunella vulgaris in thyrocytes functions as a potential mechanism for treating Hashimoto\u2019s thyroiditis","volume":"11","author":"Chen","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B31","article-title":"Bidirectional regulation of depression via the hypothalamic\u2013pituitary\u2013adrenal axis and gut\u2013brain axis from the perspective of simultaneous treatment of the liver and spleen","volume-title":"Journal of Beijing University of Traditional Chinese Medicine","author":"Nan Nan","year":"2025"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)80137-5","article-title":"Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves\u2019 disease","volume":"99","author":"Uy","year":"1995","journal-title":"Am J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0172-1","article-title":"Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management","volume":"17","author":"Vicente","year":"2017","journal-title":"Drugs R D"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1767935\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:22:12Z","timestamp":1784002932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1767935\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":36,"alternative-id":["10.3389\/fendo.2026.1767935"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1767935","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"1767935"}}